🇺🇸 FDA
Pipeline program

[14C] Antaitavir Hasophate

HEC74647-P-04/CRC-C2222

Phase 1 small_molecule completed

Quick answer

[14C] Antaitavir Hasophate for Healthy Male Subjects is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Healthy Male Subjects
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials